- Home
- CFLT vs QGEN Comparison
CFLT vs QGEN Comparison
Compare CFLT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFLT
- QGEN
- Stock Information
- Founded
- CFLT 2014
- QGEN 1986
- Country
- CFLT United States
- QGEN Netherlands
- Employees
- CFLT N/A
- QGEN N/A
- Industry
- CFLT EDP Services
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CFLT Technology
- QGEN Health Care
- Exchange
- CFLT Nasdaq
- QGEN Nasdaq
- Market Cap
- CFLT 8.5B
- QGEN 9.1B
- IPO Year
- CFLT 2021
- QGEN 1996
- Fundamental
- Price
- CFLT $24.11
- QGEN $48.08
- Analyst Decision
- CFLT Buy
- QGEN Buy
- Analyst Count
- CFLT 30
- QGEN 8
- Target Price
- CFLT $31.07
- QGEN $50.68
- AVG Volume (30 Days)
- CFLT 5.3M
- QGEN 1.3M
- Earning Date
- CFLT 07-30-2025
- QGEN 08-05-2025
- Dividend Yield
- CFLT N/A
- QGEN 3.14%
- EPS Growth
- CFLT N/A
- QGEN N/A
- EPS
- CFLT N/A
- QGEN 0.42
- Revenue
- CFLT $1,017,525,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- CFLT $21.52
- QGEN $6.36
- Revenue Next Year
- CFLT $18.27
- QGEN $6.18
- P/E Ratio
- CFLT N/A
- QGEN $115.46
- Revenue Growth
- CFLT 24.11
- QGEN 3.31
- 52 Week Low
- CFLT $17.79
- QGEN $37.63
- 52 Week High
- CFLT $37.90
- QGEN $48.90
- Technical
- Relative Strength Index (RSI)
- CFLT 50.43
- QGEN 59.71
- Support Level
- CFLT $23.88
- QGEN $47.25
- Resistance Level
- CFLT $26.70
- QGEN $48.90
- Average True Range (ATR)
- CFLT 0.92
- QGEN 0.81
- MACD
- CFLT -0.07
- QGEN -0.12
- Stochastic Oscillator
- CFLT 43.37
- QGEN 68.98
About CFLT Confluent Inc.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).